The use of 4 cycles of cisplatin-based adjuvant chemotherapy is now the standard of care for patients with resected stage II and IIIA non small cell lung cancer. Neoadjuvant chemotherapy lacks the same level of data as adjuvant treatment, but meta-analyses of this approach support its use. Selection of patients who are most likely to benefit from chemotherapy remain elusive. Ongoing adjuvant trials are exploring biomarkers, molecularly targeted agents, postoperative radiation therapy, and immunotherapy.
基金：
Clovis; Exelixis; AstraZeneca/MedImmuneAstraZeneca; Genentech/RocheRoche HoldingGenentech; BMSBristol-Myers Squibb; GileadGilead Sciences; NovartisNovartis; Xcovery; PfizerPfizer; Celgene; Pharmacyclics; Eli Lilly and CompanyEli Lilly
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2017]版：
大类|3 区医学
小类|3 区血液学4 区肿瘤学
最新[2023]版：
大类|3 区医学
小类|3 区血液学4 区肿瘤学
第一作者：
第一作者机构：[1]Stanford Hosp & Clin, Dept Med, Div Hematol, 875 Blake Wilbur Dr, Stanford, CA 94305 USA;[2]Stanford Hosp & Clin, Dept Med, Div Oncol, 875 Blake Wilbur Dr, Stanford, CA 94305 USA;
通讯作者：
通讯机构：[4]Stanford Univ, Stanford Canc Inst, Dept Med, Div Oncol, 875 Blake Wilbur Dr,Room 2233, Stanford, CA 94305 USA
推荐引用方式(GB/T 7714)：
Chuang Jody C.,Liang Ying,Wakelee Heather A..Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer[J].HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA.2017,31(1):31-+.doi:10.1016/j.hoc.2016.08.011.
APA：
Chuang, Jody C.,Liang, Ying&Wakelee, Heather A..(2017).Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA,31,(1)
MLA：
Chuang, Jody C.,et al."Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer".HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 31..1(2017):31-+
